Literature DB >> 7341094

[Clinical analysis of the therapeutic effect of semisynthetic harringtonine in treating 55 cases of nonlymphocytic leukemia (author's transl)].

Z Y Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7341094

Source DB:  PubMed          Journal:  Zhonghua Nei Ke Za Zhi        ISSN： 0578-1426


× No keyword cloud information.
  3 in total

1.  Molecular cloning and characterization of a 2C-methyl-D: -erythritol 2,4-cyclodiphosphate synthase gene from Cephalotaxus harringtonia.

Authors:  Junfeng Chen; Ying Xiao; Peng Di; Xiaojing Yu; Wansheng Chen; Lei Zhang
Journal:  Mol Biol Rep       Date:  2008-10-16       Impact factor: 2.316

Review 2.  Homoharringtonine/omacetaxine mepesuccinate: the long and winding road to food and drug administration approval.

Authors:  Hagop M Kantarjian; Susan O'Brien; Jorge Cortes
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-06-20

3.  High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China.

Authors:  Bin-Tao Huang; Qing-Chun Zeng; Jessica Yu; Xiao-Li Liu; Zhen Xiao; Hong-Qian Zhu
Journal:  Med Oncol       Date:  2011-01-22       Impact factor: 3.064
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.